Annual Net Income
-$62.68 M
-$7.40 M-13.39%
December 31, 2023
Summary
- As of February 7, 2025, LYRA annual net profit is -$62.68 million, with the most recent change of -$7.40 million (-13.39%) on December 31, 2023.
- During the last 3 years, LYRA annual net income has fallen by -$40.55 million (-183.27%).
- LYRA annual net income is now -939.64% below its all-time high of -$6.03 million, reached on December 31, 2018.
Performance
LYRA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$11.87 M
+$36.26 M+75.33%
September 30, 2024
Summary
- As of February 7, 2025, LYRA quarterly net profit is -$11.87 million, with the most recent change of +$36.26 million (+75.33%) on September 30, 2024.
- Over the past year, LYRA quarterly net income has increased by +$3.78 million (+24.14%).
- LYRA quarterly net income is now -230.82% below its all-time high of -$3.59 million, reached on March 31, 2019.
Performance
LYRA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$97.61 M
+$3.78 M+3.73%
September 30, 2024
Summary
- As of February 7, 2025, LYRA TTM net profit is -$97.61 million, with the most recent change of +$3.78 million (+3.73%) on September 30, 2024.
- Over the past year, LYRA TTM net income has dropped by -$35.85 million (-58.05%).
- LYRA TTM net income is now -2619.75% below its all-time high of -$3.59 million, reached on March 31, 2019.
Performance
LYRA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
LYRA Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.4% | +24.1% | -58.0% |
| 3 y3 years | -183.3% | +24.1% | -58.0% |
| 5 y5 years | -939.6% | +24.1% | -58.0% |
LYRA Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -44.0% | at low | at high | +75.3% | -124.3% | +3.7% |
| 5 y | 5-year | -284.4% | at low | -180.6% | +75.3% | -498.6% | +3.7% |
| alltime | all time | -939.6% | at low | -230.8% | +75.3% | -2619.8% | +3.7% |
Lyra Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.87 M(-75.3%) | -$97.61 M(-3.7%) |
| Jun 2024 | - | -$48.13 M(+114.4%) | -$101.39 M(+47.2%) |
| Mar 2024 | - | -$22.45 M(+48.1%) | -$68.88 M(+9.9%) |
| Dec 2023 | -$62.68 M(+13.4%) | -$15.16 M(-3.2%) | -$62.68 M(+1.5%) |
| Sep 2023 | - | -$15.65 M(+0.2%) | -$61.76 M(+1.5%) |
| Jun 2023 | - | -$15.62 M(-3.9%) | -$60.87 M(+2.1%) |
| Mar 2023 | - | -$16.25 M(+14.2%) | -$59.62 M(+7.9%) |
| Dec 2022 | -$55.28 M(+27.0%) | -$14.23 M(-3.6%) | -$55.28 M(+1.1%) |
| Sep 2022 | - | -$14.77 M(+2.8%) | -$54.66 M(+7.3%) |
| Jun 2022 | - | -$14.37 M(+20.6%) | -$50.95 M(+7.0%) |
| Mar 2022 | - | -$11.91 M(-12.5%) | -$47.62 M(+9.4%) |
| Dec 2021 | -$43.51 M | -$13.62 M(+23.2%) | -$43.51 M(+17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$11.05 M(+0.1%) | -$36.92 M(+14.7%) |
| Jun 2021 | - | -$11.04 M(+41.5%) | -$32.20 M(+25.3%) |
| Mar 2021 | - | -$7.80 M(+11.1%) | -$25.70 M(+16.1%) |
| Dec 2020 | -$22.13 M(+35.7%) | -$7.02 M(+10.8%) | -$22.13 M(+13.7%) |
| Sep 2020 | - | -$6.33 M(+39.5%) | -$19.46 M(+12.6%) |
| Jun 2020 | - | -$4.54 M(+7.3%) | -$17.29 M(+2.0%) |
| Mar 2020 | - | -$4.23 M(-2.8%) | -$16.95 M(+3.9%) |
| Dec 2019 | -$16.31 M(+170.5%) | -$4.35 M(+4.6%) | -$16.31 M(+36.4%) |
| Sep 2019 | - | -$4.16 M(-0.9%) | -$11.95 M(+53.4%) |
| Jun 2019 | - | -$4.20 M(+17.1%) | -$7.79 M(+117.1%) |
| Mar 2019 | - | -$3.59 M | -$3.59 M |
| Dec 2018 | -$6.03 M | - | - |
FAQ
- What is Lyra Therapeutics annual net profit?
- What is the all time high annual net income for Lyra Therapeutics?
- What is Lyra Therapeutics annual net income year-on-year change?
- What is Lyra Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly net income year-on-year change?
- What is Lyra Therapeutics TTM net profit?
- What is the all time high TTM net income for Lyra Therapeutics?
- What is Lyra Therapeutics TTM net income year-on-year change?
What is Lyra Therapeutics annual net profit?
The current annual net income of LYRA is -$62.68 M
What is the all time high annual net income for Lyra Therapeutics?
Lyra Therapeutics all-time high annual net profit is -$6.03 M
What is Lyra Therapeutics annual net income year-on-year change?
Over the past year, LYRA annual net profit has changed by -$7.40 M (-13.39%)
What is Lyra Therapeutics quarterly net profit?
The current quarterly net income of LYRA is -$11.87 M
What is the all time high quarterly net income for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly net profit is -$3.59 M
What is Lyra Therapeutics quarterly net income year-on-year change?
Over the past year, LYRA quarterly net profit has changed by +$3.78 M (+24.14%)
What is Lyra Therapeutics TTM net profit?
The current TTM net income of LYRA is -$97.61 M
What is the all time high TTM net income for Lyra Therapeutics?
Lyra Therapeutics all-time high TTM net profit is -$3.59 M
What is Lyra Therapeutics TTM net income year-on-year change?
Over the past year, LYRA TTM net profit has changed by -$35.85 M (-58.05%)